These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 23678685)

  • 1. India's decision on Gleevec: implications for the future.
    Wilensky GR
    Healthc Financ Manage; 2013 May; 67(5):32-3. PubMed ID: 23678685
    [No Abstract]   [Full Text] [Related]  

  • 2. India's patent case victory rattles Big Pharma.
    Chatterjee P
    Lancet; 2013 Apr; 381(9874):1263. PubMed ID: 23589911
    [No Abstract]   [Full Text] [Related]  

  • 3. A victory for global public health in the Indian Supreme Court.
    't Hoen E
    J Public Health Policy; 2013 Aug; 34(3):370-4. PubMed ID: 23677206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Big Pharma vs India’s Patent Office.
    Pharm Pat Anal; 2012 Nov; 1(5):529. PubMed ID: 24236921
    [No Abstract]   [Full Text] [Related]  

  • 5. India's rejection of Novartis's patent is but a small step in the right direction.
    Bhaumik S
    BMJ; 2013 Apr; 346():f2412. PubMed ID: 23596223
    [No Abstract]   [Full Text] [Related]  

  • 6. How can the public health community help to invigorate a 'health first' perspective in global drug development debates?
    Freeman P; Robbins A
    J Public Health Policy; 2013 Aug; 34(3):361-9. PubMed ID: 23803714
    [No Abstract]   [Full Text] [Related]  

  • 7. Intellectual property. Challenges to India's pharmaceutical patent laws.
    Sampat BN; Shadlen KC; Amin TM
    Science; 2012 Jul; 337(6093):414-5. PubMed ID: 22767892
    [No Abstract]   [Full Text] [Related]  

  • 8. Will the refusal of patent protection for Glivec® discourage future pharmaceutical innovation in India?
    Albutt J
    Pharm Pat Anal; 2013 Jul; 2(4):439-41. PubMed ID: 24237119
    [No Abstract]   [Full Text] [Related]  

  • 9. "To patent or not to patent? the case of Novartis' cancer drug Glivec in India".
    Gabble R; Kohler JC
    Global Health; 2014 Jan; 10():3. PubMed ID: 24393270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Indian Supreme Court's judgment in the case of Glivec(®) - the uncertain future of pharmaceutical patents in India.
    Thikkavarapu PR
    Pharm Pat Anal; 2014 Mar; 3(2):117-9. PubMed ID: 24588585
    [No Abstract]   [Full Text] [Related]  

  • 11. Supreme Court of India rejects Novartis’ cancer drug patent.
    Heseltine P
    Pharm Pat Anal; 2013 May; 2(3):299-300. PubMed ID: 24237056
    [No Abstract]   [Full Text] [Related]  

  • 12. Indian Supreme Court rejects Novartis's appeal on drug patent.
    Arie S
    BMJ; 2013 Apr; 346():f2099. PubMed ID: 23550079
    [No Abstract]   [Full Text] [Related]  

  • 13. A modest but meaningful decision for Indian drug patents.
    Attaran A
    Lancet; 2014 Aug; 384(9942):477-9. PubMed ID: 24976117
    [No Abstract]   [Full Text] [Related]  

  • 14. Engineered in India--patent law 2.0.
    Kapczynski A
    N Engl J Med; 2013 Aug; 369(6):497-9. PubMed ID: 23862973
    [No Abstract]   [Full Text] [Related]  

  • 15. Drugmakers struggle with Indian patents.
    Cancer Discov; 2012 Dec; 2(12):OF5. PubMed ID: 23230206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MSF challenges Novartis's action over Indian patent for imatinib.
    Mudur G
    BMJ; 2007 Jan; 334(7586):172. PubMed ID: 17255582
    [No Abstract]   [Full Text] [Related]  

  • 17. Images in pathology. Morphologic features of response to Gleevec (Imatinib) treatment of GIST.
    Colecchia M; Diment J
    Int J Surg Pathol; 2003 Apr; 11(2):119. PubMed ID: 12754630
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful progressive challenge after a cutaneous reaction to imatinib mesylate (Gleevec): a case report and review of the literature.
    Park MA; Volcheck GW; Guarderas JC
    Allergy Asthma Proc; 2004; 25(5):345-7. PubMed ID: 15603208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patent news.
    Steele P; Sparrowhawk M
    IDrugs; 2003 Dec; 6(12):1195-7. PubMed ID: 14712831
    [No Abstract]   [Full Text] [Related]  

  • 20. Pityriasis rosea associated with imatinib (STI571, Gleevec).
    Konstantopoulos K; Papadogianni A; Dimopoulou M; Kourelis C; Meletis J
    Dermatology; 2002; 205(2):172-3. PubMed ID: 12218236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.